FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称POLATUZUMAB VEDOTIN
异名/同义词ACD79B-VCMMAE
ACD-79BVCMMAE
ACD-79B-VCMMAE
ANTI-CD79B ADC
ANTI-CD79B ANTIBODY-DRUG CONJUGATE, ANTI-CD79B-VC-MMAE
ANTI-CD79B MONOCLONAL ANTIBODY CONJUGATED TO MONOMETHYL AURISTATIN E (MMAE)
DCDS4501A
DCDS-4501A
FCU2711
FCU-2711
IMMUNOGLOBULIN G1-KAPPA AURISTATIN E CONJUGATE, ANTI-(HOMO SAPIENS CD79B (IMMUNOGLOBULIN-ASSOCIATED CD79 BETA)), HUMANIZED MONOCLONAL ANTIBODY CONJUGATED TO AURISTATIN E
POLATUZUMAB VEDOTIN
POLATUZUMAB VEDOTIN [INN]
POLATUZUMAB VEDOTIN [JAN]
POLATUZUMAB VEDOTIN [MI]
POLATUZUMAB VEDOTIN [USAN]
POLATUZUMAB VEDOTIN [WHO-DD]
POLATUZUMAB VEDOTIN PIIQ [WHO-DD]
POLATUZUMAB VEDOTIN-PIIQ
POLIVY
RG7596
RG-7596
RO5541077-000
RO-5541077000
RO-5541077-000
CAS登记号1313206-42-6
物质唯一标识(Unique Ingredient Identifier)KG6VO684Z6
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System